There were also reports showing circulating IDO level correlations with overall survival, progression-free survival, and distant metastasis of patients with breast cancer, lung cancer, melanoma, and glioblastoma [90, 91, 93, 94]. This evidence concerns the gene IDO1 and lung carcinoma.